Global Isatuximab Market 2026 by Manufacturers, Regions, Type and Application, Forecast to 2032
According to our (Global Info Research) latest study, the global Isatuximab market size was valued at US$ 648 million in 2025 and is forecast to a readjusted size of US$ 1740 million by 2032 with a CAGR of 13.8% during review period.
Isatuximab is a humanized monoclonal antibody targeting CD38, primarily used in the treatment of hematologic malignancies such as multiple myeloma. It exerts its anti-tumor effects by specifically binding to the CD38 antigen expressed on the surface of tumor cells, thereby inducing multiple immune-mediated mechanisms, including antibody-dependent cellular cytotoxicity (ADCC), complement-dependent cytotoxicity (CDC), and direct induction of tumor cell apoptosis. Isatuximab is typically used in combination with immunomodulatory agents or proteasome inhibitors for patients with relapsed or refractory multiple myeloma, and has significant clinical value in the field of hematologic cancer targeted therapy.In 2025, global Isatuximab production reached approximately 120,000 units.
Isatuximab, as a CD38-targeting monoclonal antibody, holds an important position in the treatment market for multiple myeloma. With the acceleration of global aging and the gradual increase in the incidence of multiple myeloma, the demand for hematologic cancer therapies continues to grow, driving the expansion of the CD38-targeted drug market. Isatuximab has steadily increased its market penetration due to its clinical efficacy in relapsed or refractory patients and its growing use in frontline combination therapy regimens. From a competitive landscape perspective, this field is primarily dominated by early entrants such as daratumumab. However, Isatuximab is gradually gaining market share through differentiated clinical data and combination treatment strategies. Looking ahead, with the approval of more frontline indications, the standardization of combination therapies, and further expansion into global markets, the market size of Isatuximab is expected to maintain steady growth, continuing to play an important role in the CD38-targeted therapy landscape.
This report is a detailed and comprehensive analysis for global Isatuximab market. Both quantitative and qualitative analyses are presented by manufacturers, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2025, are provided.
Key Features:
Global Isatuximab market size and forecasts, in consumption value ($ Million), sales quantity (Units), and average selling prices (US$/Unit), 2021-2032
Global Isatuximab market size and forecasts by region and country, in consumption value ($ Million), sales quantity (Units), and average selling prices (US$/Unit), 2021-2032
Global Isatuximab market size and forecasts, by Type and by Application, in consumption value ($ Million), sales quantity (Units), and average selling prices (US$/Unit), 2021-2032
Global Isatuximab market shares of main players, shipments in revenue ($ Million), sales quantity (Units), and ASP (US$/Unit), 2021-2026
The Primary Objectives in This Report Are:
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
Market Segmentation
Isatuximab market is split by Type and by Application. For the period 2021-2032, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type
Chapter 1, to describe Isatuximab product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top manufacturers of Isatuximab, with price, sales quantity, revenue, and global market share of Isatuximab from 2021 to 2026.
Chapter 3, the Isatuximab competitive situation, sales quantity, revenue, and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Isatuximab breakdown data are shown at the regional level, to show the sales quantity, consumption value, and growth by regions, from 2021 to 2032.
Chapter 5 and 6, to segment the sales by Type and by Application, with sales market share and growth rate by Type, by Application, from 2021 to 2032.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value, and market share for key countries in the world, from 2021 to 2026.and Isatuximab market forecast, by regions, by Type, and by Application, with sales and revenue, from 2027 to 2032.
Chapter 12, market dynamics, drivers, restraints, trends, and Porters Five Forces analysis.
Chapter 13, the key raw materials and key suppliers, and industry chain of Isatuximab.
Chapter 14 and 15, to describe Isatuximab sales channel, distributors, customers, research findings and conclusion.
Isatuximab is a humanized monoclonal antibody targeting CD38, primarily used in the treatment of hematologic malignancies such as multiple myeloma. It exerts its anti-tumor effects by specifically binding to the CD38 antigen expressed on the surface of tumor cells, thereby inducing multiple immune-mediated mechanisms, including antibody-dependent cellular cytotoxicity (ADCC), complement-dependent cytotoxicity (CDC), and direct induction of tumor cell apoptosis. Isatuximab is typically used in combination with immunomodulatory agents or proteasome inhibitors for patients with relapsed or refractory multiple myeloma, and has significant clinical value in the field of hematologic cancer targeted therapy.In 2025, global Isatuximab production reached approximately 120,000 units.
Isatuximab, as a CD38-targeting monoclonal antibody, holds an important position in the treatment market for multiple myeloma. With the acceleration of global aging and the gradual increase in the incidence of multiple myeloma, the demand for hematologic cancer therapies continues to grow, driving the expansion of the CD38-targeted drug market. Isatuximab has steadily increased its market penetration due to its clinical efficacy in relapsed or refractory patients and its growing use in frontline combination therapy regimens. From a competitive landscape perspective, this field is primarily dominated by early entrants such as daratumumab. However, Isatuximab is gradually gaining market share through differentiated clinical data and combination treatment strategies. Looking ahead, with the approval of more frontline indications, the standardization of combination therapies, and further expansion into global markets, the market size of Isatuximab is expected to maintain steady growth, continuing to play an important role in the CD38-targeted therapy landscape.
This report is a detailed and comprehensive analysis for global Isatuximab market. Both quantitative and qualitative analyses are presented by manufacturers, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2025, are provided.
Key Features:
Global Isatuximab market size and forecasts, in consumption value ($ Million), sales quantity (Units), and average selling prices (US$/Unit), 2021-2032
Global Isatuximab market size and forecasts by region and country, in consumption value ($ Million), sales quantity (Units), and average selling prices (US$/Unit), 2021-2032
Global Isatuximab market size and forecasts, by Type and by Application, in consumption value ($ Million), sales quantity (Units), and average selling prices (US$/Unit), 2021-2032
Global Isatuximab market shares of main players, shipments in revenue ($ Million), sales quantity (Units), and ASP (US$/Unit), 2021-2026
The Primary Objectives in This Report Are:
- To determine the size of the total market opportunity of global and key countries
- To assess the growth potential for Isatuximab
- To forecast future growth in each product and end-use market
- To assess competitive factors affecting the marketplace
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
Market Segmentation
Isatuximab market is split by Type and by Application. For the period 2021-2032, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type
- Monoclonal Antibody, mAb
- Polyclonal Antibody, pAb
- 100 mg / 5 mL
- 500 mg / 25 mL
- Hospital
- Retail
- Online
- Relapsed or Refractory Multiple Myeloma (R/R MM)
- Frontline Multiple Myeloma (Frontline MM)
- CD38-Positive Hematologic Malignancies
- Precision Hematologic Cancer Therapy
- Others
- Sanofi
- Sanofi Winthrop Industrie
- North America (United States, Canada, and Mexico)
- Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
- Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
- South America (Brazil, Argentina, Colombia, and Rest of South America)
- Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
Chapter 1, to describe Isatuximab product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top manufacturers of Isatuximab, with price, sales quantity, revenue, and global market share of Isatuximab from 2021 to 2026.
Chapter 3, the Isatuximab competitive situation, sales quantity, revenue, and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Isatuximab breakdown data are shown at the regional level, to show the sales quantity, consumption value, and growth by regions, from 2021 to 2032.
Chapter 5 and 6, to segment the sales by Type and by Application, with sales market share and growth rate by Type, by Application, from 2021 to 2032.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value, and market share for key countries in the world, from 2021 to 2026.and Isatuximab market forecast, by regions, by Type, and by Application, with sales and revenue, from 2027 to 2032.
Chapter 12, market dynamics, drivers, restraints, trends, and Porters Five Forces analysis.
Chapter 13, the key raw materials and key suppliers, and industry chain of Isatuximab.
Chapter 14 and 15, to describe Isatuximab sales channel, distributors, customers, research findings and conclusion.
1 MARKET OVERVIEW
1.1 Product Overview and Scope
1.2 Market Estimation Caveats and Base Year
1.3 Market Analysis by Type
1.3.1 Overview: Global Isatuximab Consumption Value by Type: 2021 Versus 2025 Versus 2032
1.3.2 Monoclonal Antibody, mAb
1.3.3 Polyclonal Antibody, pAb
1.4 Market Analysis by Specification
1.4.1 Overview: Global Isatuximab Consumption Value by Specification: 2021 Versus 2025 Versus 2032
1.4.2 100 mg / 5 mL
1.4.3 500 mg / 25 mL
1.5 Market Analysis by Route of Administration
1.5.1 Overview: Global Isatuximab Consumption Value by Route of Administration: 2021 Versus 2025 Versus 2032
1.5.2 Hospital
1.5.3 Retail
1.5.4 Online
1.6 Market Analysis by Application
1.6.1 Overview: Global Isatuximab Consumption Value by Application: 2021 Versus 2025 Versus 2032
1.6.2 Relapsed or Refractory Multiple Myeloma (R/R MM)
1.6.3 Frontline Multiple Myeloma (Frontline MM)
1.6.4 CD38-Positive Hematologic Malignancies
1.6.5 Precision Hematologic Cancer Therapy
1.6.6 Others
1.7 Global Isatuximab Market Size & Forecast
1.7.1 Global Isatuximab Consumption Value (2021 & 2025 & 2032)
1.7.2 Global Isatuximab Sales Quantity (2021-2032)
1.7.3 Global Isatuximab Average Price (2021-2032)
2 MANUFACTURERS PROFILES
2.1 Sanofi
2.1.1 Sanofi Details
2.1.2 Sanofi Major Business
2.1.3 Sanofi Isatuximab Product and Services
2.1.4 Sanofi Isatuximab Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
2.1.5 Sanofi Recent Developments/Updates
2.2 Sanofi Winthrop Industrie
2.2.1 Sanofi Winthrop Industrie Details
2.2.2 Sanofi Winthrop Industrie Major Business
2.2.3 Sanofi Winthrop Industrie Isatuximab Product and Services
2.2.4 Sanofi Winthrop Industrie Isatuximab Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
2.2.5 Sanofi Winthrop Industrie Recent Developments/Updates
3 COMPETITIVE ENVIRONMENT: ISATUXIMAB BY MANUFACTURER
3.1 Global Isatuximab Sales Quantity by Manufacturer (2021-2026)
3.2 Global Isatuximab Revenue by Manufacturer (2021-2026)
3.3 Global Isatuximab Average Price by Manufacturer (2021-2026)
3.4 Market Share Analysis (2025)
3.4.1 Producer Shipments of Isatuximab by Manufacturer Revenue ($MM) and Market Share (%): 2025
3.4.2 Top 3 Isatuximab Manufacturer Market Share in 2025
3.4.3 Top 6 Isatuximab Manufacturer Market Share in 2025
3.5 Isatuximab Market: Overall Company Footprint Analysis
3.5.1 Isatuximab Market: Region Footprint
3.5.2 Isatuximab Market: Company Product Type Footprint
3.5.3 Isatuximab Market: Company Product Application Footprint
3.6 New Market Entrants and Barriers to Market Entry
3.7 Mergers, Acquisition, Agreements, and Collaborations
4 CONSUMPTION ANALYSIS BY REGION
4.1 Global Isatuximab Market Size by Region
4.1.1 Global Isatuximab Sales Quantity by Region (2021-2032)
4.1.2 Global Isatuximab Consumption Value by Region (2021-2032)
4.1.3 Global Isatuximab Average Price by Region (2021-2032)
4.2 North America Isatuximab Consumption Value (2021-2032)
4.3 Europe Isatuximab Consumption Value (2021-2032)
4.4 Asia-Pacific Isatuximab Consumption Value (2021-2032)
4.5 South America Isatuximab Consumption Value (2021-2032)
4.6 Middle East & Africa Isatuximab Consumption Value (2021-2032)
5 MARKET SEGMENT BY TYPE
5.1 Global Isatuximab Sales Quantity by Type (2021-2032)
5.2 Global Isatuximab Consumption Value by Type (2021-2032)
5.3 Global Isatuximab Average Price by Type (2021-2032)
6 MARKET SEGMENT BY APPLICATION
6.1 Global Isatuximab Sales Quantity by Application (2021-2032)
6.2 Global Isatuximab Consumption Value by Application (2021-2032)
6.3 Global Isatuximab Average Price by Application (2021-2032)
7 NORTH AMERICA
7.1 North America Isatuximab Sales Quantity by Type (2021-2032)
7.2 North America Isatuximab Sales Quantity by Application (2021-2032)
7.3 North America Isatuximab Market Size by Country
7.3.1 North America Isatuximab Sales Quantity by Country (2021-2032)
7.3.2 North America Isatuximab Consumption Value by Country (2021-2032)
7.3.3 United States Market Size and Forecast (2021-2032)
7.3.4 Canada Market Size and Forecast (2021-2032)
7.3.5 Mexico Market Size and Forecast (2021-2032)
8 EUROPE
8.1 Europe Isatuximab Sales Quantity by Type (2021-2032)
8.2 Europe Isatuximab Sales Quantity by Application (2021-2032)
8.3 Europe Isatuximab Market Size by Country
8.3.1 Europe Isatuximab Sales Quantity by Country (2021-2032)
8.3.2 Europe Isatuximab Consumption Value by Country (2021-2032)
8.3.3 Germany Market Size and Forecast (2021-2032)
8.3.4 France Market Size and Forecast (2021-2032)
8.3.5 United Kingdom Market Size and Forecast (2021-2032)
8.3.6 Russia Market Size and Forecast (2021-2032)
8.3.7 Italy Market Size and Forecast (2021-2032)
9 ASIA-PACIFIC
9.1 Asia-Pacific Isatuximab Sales Quantity by Type (2021-2032)
9.2 Asia-Pacific Isatuximab Sales Quantity by Application (2021-2032)
9.3 Asia-Pacific Isatuximab Market Size by Region
9.3.1 Asia-Pacific Isatuximab Sales Quantity by Region (2021-2032)
9.3.2 Asia-Pacific Isatuximab Consumption Value by Region (2021-2032)
9.3.3 China Market Size and Forecast (2021-2032)
9.3.4 Japan Market Size and Forecast (2021-2032)
9.3.5 South Korea Market Size and Forecast (2021-2032)
9.3.6 India Market Size and Forecast (2021-2032)
9.3.7 Southeast Asia Market Size and Forecast (2021-2032)
9.3.8 Australia Market Size and Forecast (2021-2032)
10 SOUTH AMERICA
10.1 South America Isatuximab Sales Quantity by Type (2021-2032)
10.2 South America Isatuximab Sales Quantity by Application (2021-2032)
10.3 South America Isatuximab Market Size by Country
10.3.1 South America Isatuximab Sales Quantity by Country (2021-2032)
10.3.2 South America Isatuximab Consumption Value by Country (2021-2032)
10.3.3 Brazil Market Size and Forecast (2021-2032)
10.3.4 Argentina Market Size and Forecast (2021-2032)
11 MIDDLE EAST & AFRICA
11.1 Middle East & Africa Isatuximab Sales Quantity by Type (2021-2032)
11.2 Middle East & Africa Isatuximab Sales Quantity by Application (2021-2032)
11.3 Middle East & Africa Isatuximab Market Size by Country
11.3.1 Middle East & Africa Isatuximab Sales Quantity by Country (2021-2032)
11.3.2 Middle East & Africa Isatuximab Consumption Value by Country (2021-2032)
11.3.3 Turkey Market Size and Forecast (2021-2032)
11.3.4 Egypt Market Size and Forecast (2021-2032)
11.3.5 Saudi Arabia Market Size and Forecast (2021-2032)
11.3.6 South Africa Market Size and Forecast (2021-2032)
12 MARKET DYNAMICS
12.1 Isatuximab Market Drivers
12.2 Isatuximab Market Restraints
12.3 Isatuximab Trends Analysis
12.4 Porters Five Forces Analysis
12.4.1 Threat of New Entrants
12.4.2 Bargaining Power of Suppliers
12.4.3 Bargaining Power of Buyers
12.4.4 Threat of Substitutes
12.4.5 Competitive Rivalry
13 RAW MATERIAL AND INDUSTRY CHAIN
13.1 Raw Material of Isatuximab and Key Manufacturers
13.2 Manufacturing Costs Percentage of Isatuximab
13.3 Isatuximab Production Process
13.4 Industry Value Chain Analysis
14 SHIPMENTS BY DISTRIBUTION CHANNEL
14.1 Sales Channel
14.1.1 Direct to End-User
14.1.2 Distributors
14.2 Isatuximab Typical Distributors
14.3 Isatuximab Typical Customers
15 RESEARCH FINDINGS AND CONCLUSION
16 APPENDIX
16.1 Methodology
16.2 Research Process and Data Source
16.3 Disclaimer
1.1 Product Overview and Scope
1.2 Market Estimation Caveats and Base Year
1.3 Market Analysis by Type
1.3.1 Overview: Global Isatuximab Consumption Value by Type: 2021 Versus 2025 Versus 2032
1.3.2 Monoclonal Antibody, mAb
1.3.3 Polyclonal Antibody, pAb
1.4 Market Analysis by Specification
1.4.1 Overview: Global Isatuximab Consumption Value by Specification: 2021 Versus 2025 Versus 2032
1.4.2 100 mg / 5 mL
1.4.3 500 mg / 25 mL
1.5 Market Analysis by Route of Administration
1.5.1 Overview: Global Isatuximab Consumption Value by Route of Administration: 2021 Versus 2025 Versus 2032
1.5.2 Hospital
1.5.3 Retail
1.5.4 Online
1.6 Market Analysis by Application
1.6.1 Overview: Global Isatuximab Consumption Value by Application: 2021 Versus 2025 Versus 2032
1.6.2 Relapsed or Refractory Multiple Myeloma (R/R MM)
1.6.3 Frontline Multiple Myeloma (Frontline MM)
1.6.4 CD38-Positive Hematologic Malignancies
1.6.5 Precision Hematologic Cancer Therapy
1.6.6 Others
1.7 Global Isatuximab Market Size & Forecast
1.7.1 Global Isatuximab Consumption Value (2021 & 2025 & 2032)
1.7.2 Global Isatuximab Sales Quantity (2021-2032)
1.7.3 Global Isatuximab Average Price (2021-2032)
2 MANUFACTURERS PROFILES
2.1 Sanofi
2.1.1 Sanofi Details
2.1.2 Sanofi Major Business
2.1.3 Sanofi Isatuximab Product and Services
2.1.4 Sanofi Isatuximab Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
2.1.5 Sanofi Recent Developments/Updates
2.2 Sanofi Winthrop Industrie
2.2.1 Sanofi Winthrop Industrie Details
2.2.2 Sanofi Winthrop Industrie Major Business
2.2.3 Sanofi Winthrop Industrie Isatuximab Product and Services
2.2.4 Sanofi Winthrop Industrie Isatuximab Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
2.2.5 Sanofi Winthrop Industrie Recent Developments/Updates
3 COMPETITIVE ENVIRONMENT: ISATUXIMAB BY MANUFACTURER
3.1 Global Isatuximab Sales Quantity by Manufacturer (2021-2026)
3.2 Global Isatuximab Revenue by Manufacturer (2021-2026)
3.3 Global Isatuximab Average Price by Manufacturer (2021-2026)
3.4 Market Share Analysis (2025)
3.4.1 Producer Shipments of Isatuximab by Manufacturer Revenue ($MM) and Market Share (%): 2025
3.4.2 Top 3 Isatuximab Manufacturer Market Share in 2025
3.4.3 Top 6 Isatuximab Manufacturer Market Share in 2025
3.5 Isatuximab Market: Overall Company Footprint Analysis
3.5.1 Isatuximab Market: Region Footprint
3.5.2 Isatuximab Market: Company Product Type Footprint
3.5.3 Isatuximab Market: Company Product Application Footprint
3.6 New Market Entrants and Barriers to Market Entry
3.7 Mergers, Acquisition, Agreements, and Collaborations
4 CONSUMPTION ANALYSIS BY REGION
4.1 Global Isatuximab Market Size by Region
4.1.1 Global Isatuximab Sales Quantity by Region (2021-2032)
4.1.2 Global Isatuximab Consumption Value by Region (2021-2032)
4.1.3 Global Isatuximab Average Price by Region (2021-2032)
4.2 North America Isatuximab Consumption Value (2021-2032)
4.3 Europe Isatuximab Consumption Value (2021-2032)
4.4 Asia-Pacific Isatuximab Consumption Value (2021-2032)
4.5 South America Isatuximab Consumption Value (2021-2032)
4.6 Middle East & Africa Isatuximab Consumption Value (2021-2032)
5 MARKET SEGMENT BY TYPE
5.1 Global Isatuximab Sales Quantity by Type (2021-2032)
5.2 Global Isatuximab Consumption Value by Type (2021-2032)
5.3 Global Isatuximab Average Price by Type (2021-2032)
6 MARKET SEGMENT BY APPLICATION
6.1 Global Isatuximab Sales Quantity by Application (2021-2032)
6.2 Global Isatuximab Consumption Value by Application (2021-2032)
6.3 Global Isatuximab Average Price by Application (2021-2032)
7 NORTH AMERICA
7.1 North America Isatuximab Sales Quantity by Type (2021-2032)
7.2 North America Isatuximab Sales Quantity by Application (2021-2032)
7.3 North America Isatuximab Market Size by Country
7.3.1 North America Isatuximab Sales Quantity by Country (2021-2032)
7.3.2 North America Isatuximab Consumption Value by Country (2021-2032)
7.3.3 United States Market Size and Forecast (2021-2032)
7.3.4 Canada Market Size and Forecast (2021-2032)
7.3.5 Mexico Market Size and Forecast (2021-2032)
8 EUROPE
8.1 Europe Isatuximab Sales Quantity by Type (2021-2032)
8.2 Europe Isatuximab Sales Quantity by Application (2021-2032)
8.3 Europe Isatuximab Market Size by Country
8.3.1 Europe Isatuximab Sales Quantity by Country (2021-2032)
8.3.2 Europe Isatuximab Consumption Value by Country (2021-2032)
8.3.3 Germany Market Size and Forecast (2021-2032)
8.3.4 France Market Size and Forecast (2021-2032)
8.3.5 United Kingdom Market Size and Forecast (2021-2032)
8.3.6 Russia Market Size and Forecast (2021-2032)
8.3.7 Italy Market Size and Forecast (2021-2032)
9 ASIA-PACIFIC
9.1 Asia-Pacific Isatuximab Sales Quantity by Type (2021-2032)
9.2 Asia-Pacific Isatuximab Sales Quantity by Application (2021-2032)
9.3 Asia-Pacific Isatuximab Market Size by Region
9.3.1 Asia-Pacific Isatuximab Sales Quantity by Region (2021-2032)
9.3.2 Asia-Pacific Isatuximab Consumption Value by Region (2021-2032)
9.3.3 China Market Size and Forecast (2021-2032)
9.3.4 Japan Market Size and Forecast (2021-2032)
9.3.5 South Korea Market Size and Forecast (2021-2032)
9.3.6 India Market Size and Forecast (2021-2032)
9.3.7 Southeast Asia Market Size and Forecast (2021-2032)
9.3.8 Australia Market Size and Forecast (2021-2032)
10 SOUTH AMERICA
10.1 South America Isatuximab Sales Quantity by Type (2021-2032)
10.2 South America Isatuximab Sales Quantity by Application (2021-2032)
10.3 South America Isatuximab Market Size by Country
10.3.1 South America Isatuximab Sales Quantity by Country (2021-2032)
10.3.2 South America Isatuximab Consumption Value by Country (2021-2032)
10.3.3 Brazil Market Size and Forecast (2021-2032)
10.3.4 Argentina Market Size and Forecast (2021-2032)
11 MIDDLE EAST & AFRICA
11.1 Middle East & Africa Isatuximab Sales Quantity by Type (2021-2032)
11.2 Middle East & Africa Isatuximab Sales Quantity by Application (2021-2032)
11.3 Middle East & Africa Isatuximab Market Size by Country
11.3.1 Middle East & Africa Isatuximab Sales Quantity by Country (2021-2032)
11.3.2 Middle East & Africa Isatuximab Consumption Value by Country (2021-2032)
11.3.3 Turkey Market Size and Forecast (2021-2032)
11.3.4 Egypt Market Size and Forecast (2021-2032)
11.3.5 Saudi Arabia Market Size and Forecast (2021-2032)
11.3.6 South Africa Market Size and Forecast (2021-2032)
12 MARKET DYNAMICS
12.1 Isatuximab Market Drivers
12.2 Isatuximab Market Restraints
12.3 Isatuximab Trends Analysis
12.4 Porters Five Forces Analysis
12.4.1 Threat of New Entrants
12.4.2 Bargaining Power of Suppliers
12.4.3 Bargaining Power of Buyers
12.4.4 Threat of Substitutes
12.4.5 Competitive Rivalry
13 RAW MATERIAL AND INDUSTRY CHAIN
13.1 Raw Material of Isatuximab and Key Manufacturers
13.2 Manufacturing Costs Percentage of Isatuximab
13.3 Isatuximab Production Process
13.4 Industry Value Chain Analysis
14 SHIPMENTS BY DISTRIBUTION CHANNEL
14.1 Sales Channel
14.1.1 Direct to End-User
14.1.2 Distributors
14.2 Isatuximab Typical Distributors
14.3 Isatuximab Typical Customers
15 RESEARCH FINDINGS AND CONCLUSION
16 APPENDIX
16.1 Methodology
16.2 Research Process and Data Source
16.3 Disclaimer
LIST OF TABLES
Table 1. Global Isatuximab Consumption Value by Type, (USD Million), 2021 & 2025 & 2032
Table 2. Global Isatuximab Consumption Value by Specification, (USD Million), 2021 & 2025 & 2032
Table 3. Global Isatuximab Consumption Value by Route of Administration, (USD Million), 2021 & 2025 & 2032
Table 4. Global Isatuximab Consumption Value by Application, (USD Million), 2021 & 2025 & 2032
Table 5. Sanofi Basic Information, Manufacturing Base and Competitors
Table 6. Sanofi Major Business
Table 7. Sanofi Isatuximab Product and Services
Table 8. Sanofi Isatuximab Sales Quantity (Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 9. Sanofi Recent Developments/Updates
Table 10. Sanofi Winthrop Industrie Basic Information, Manufacturing Base and Competitors
Table 11. Sanofi Winthrop Industrie Major Business
Table 12. Sanofi Winthrop Industrie Isatuximab Product and Services
Table 13. Sanofi Winthrop Industrie Isatuximab Sales Quantity (Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 14. Sanofi Winthrop Industrie Recent Developments/Updates
Table 15. Global Isatuximab Sales Quantity by Manufacturer (2021-2026) & (Units)
Table 16. Global Isatuximab Revenue by Manufacturer (2021-2026) & (USD Million)
Table 17. Global Isatuximab Average Price by Manufacturer (2021-2026) & (US$/Unit)
Table 18. Market Position of Manufacturers in Isatuximab, (Tier 1, Tier 2, and Tier 3), Based on Revenue in 2025
Table 19. Head Office and Isatuximab Production Site of Key Manufacturer
Table 20. Isatuximab Market: Company Product Type Footprint
Table 21. Isatuximab Market: Company Product Application Footprint
Table 22. Isatuximab New Market Entrants and Barriers to Market Entry
Table 23. Isatuximab Mergers, Acquisition, Agreements, and Collaborations
Table 24. Global Isatuximab Consumption Value by Region (2021-2025-2032) & (USD Million) & CAGR
Table 25. Global Isatuximab Sales Quantity by Region (2021-2026) & (Units)
Table 26. Global Isatuximab Sales Quantity by Region (2027-2032) & (Units)
Table 27. Global Isatuximab Consumption Value by Region (2021-2026) & (USD Million)
Table 28. Global Isatuximab Consumption Value by Region (2027-2032) & (USD Million)
Table 29. Global Isatuximab Average Price by Region (2021-2026) & (US$/Unit)
Table 30. Global Isatuximab Average Price by Region (2027-2032) & (US$/Unit)
Table 31. Global Isatuximab Sales Quantity by Type (2021-2026) & (Units)
Table 32. Global Isatuximab Sales Quantity by Type (2027-2032) & (Units)
Table 33. Global Isatuximab Consumption Value by Type (2021-2026) & (USD Million)
Table 34. Global Isatuximab Consumption Value by Type (2027-2032) & (USD Million)
Table 35. Global Isatuximab Average Price by Type (2021-2026) & (US$/Unit)
Table 36. Global Isatuximab Average Price by Type (2027-2032) & (US$/Unit)
Table 37. Global Isatuximab Sales Quantity by Application (2021-2026) & (Units)
Table 38. Global Isatuximab Sales Quantity by Application (2027-2032) & (Units)
Table 39. Global Isatuximab Consumption Value by Application (2021-2026) & (USD Million)
Table 40. Global Isatuximab Consumption Value by Application (2027-2032) & (USD Million)
Table 41. Global Isatuximab Average Price by Application (2021-2026) & (US$/Unit)
Table 42. Global Isatuximab Average Price by Application (2027-2032) & (US$/Unit)
Table 43. North America Isatuximab Sales Quantity by Type (2021-2026) & (Units)
Table 44. North America Isatuximab Sales Quantity by Type (2027-2032) & (Units)
Table 45. North America Isatuximab Sales Quantity by Application (2021-2026) & (Units)
Table 46. North America Isatuximab Sales Quantity by Application (2027-2032) & (Units)
Table 47. North America Isatuximab Sales Quantity by Country (2021-2026) & (Units)
Table 48. North America Isatuximab Sales Quantity by Country (2027-2032) & (Units)
Table 49. North America Isatuximab Consumption Value by Country (2021-2026) & (USD Million)
Table 50. North America Isatuximab Consumption Value by Country (2027-2032) & (USD Million)
Table 51. Europe Isatuximab Sales Quantity by Type (2021-2026) & (Units)
Table 52. Europe Isatuximab Sales Quantity by Type (2027-2032) & (Units)
Table 53. Europe Isatuximab Sales Quantity by Application (2021-2026) & (Units)
Table 54. Europe Isatuximab Sales Quantity by Application (2027-2032) & (Units)
Table 55. Europe Isatuximab Sales Quantity by Country (2021-2026) & (Units)
Table 56. Europe Isatuximab Sales Quantity by Country (2027-2032) & (Units)
Table 57. Europe Isatuximab Consumption Value by Country (2021-2026) & (USD Million)
Table 58. Europe Isatuximab Consumption Value by Country (2027-2032) & (USD Million)
Table 59. Asia-Pacific Isatuximab Sales Quantity by Type (2021-2026) & (Units)
Table 60. Asia-Pacific Isatuximab Sales Quantity by Type (2027-2032) & (Units)
Table 61. Asia-Pacific Isatuximab Sales Quantity by Application (2021-2026) & (Units)
Table 62. Asia-Pacific Isatuximab Sales Quantity by Application (2027-2032) & (Units)
Table 63. Asia-Pacific Isatuximab Sales Quantity by Region (2021-2026) & (Units)
Table 64. Asia-Pacific Isatuximab Sales Quantity by Region (2027-2032) & (Units)
Table 65. Asia-Pacific Isatuximab Consumption Value by Region (2021-2026) & (USD Million)
Table 66. Asia-Pacific Isatuximab Consumption Value by Region (2027-2032) & (USD Million)
Table 67. South America Isatuximab Sales Quantity by Type (2021-2026) & (Units)
Table 68. South America Isatuximab Sales Quantity by Type (2027-2032) & (Units)
Table 69. South America Isatuximab Sales Quantity by Application (2021-2026) & (Units)
Table 70. South America Isatuximab Sales Quantity by Application (2027-2032) & (Units)
Table 71. South America Isatuximab Sales Quantity by Country (2021-2026) & (Units)
Table 72. South America Isatuximab Sales Quantity by Country (2027-2032) & (Units)
Table 73. South America Isatuximab Consumption Value by Country (2021-2026) & (USD Million)
Table 74. South America Isatuximab Consumption Value by Country (2027-2032) & (USD Million)
Table 75. Middle East & Africa Isatuximab Sales Quantity by Type (2021-2026) & (Units)
Table 76. Middle East & Africa Isatuximab Sales Quantity by Type (2027-2032) & (Units)
Table 77. Middle East & Africa Isatuximab Sales Quantity by Application (2021-2026) & (Units)
Table 78. Middle East & Africa Isatuximab Sales Quantity by Application (2027-2032) & (Units)
Table 79. Middle East & Africa Isatuximab Sales Quantity by Country (2021-2026) & (Units)
Table 80. Middle East & Africa Isatuximab Sales Quantity by Country (2027-2032) & (Units)
Table 81. Middle East & Africa Isatuximab Consumption Value by Country (2021-2026) & (USD Million)
Table 82. Middle East & Africa Isatuximab Consumption Value by Country (2027-2032) & (USD Million)
Table 83. Isatuximab Raw Material
Table 84. Key Manufacturers of Isatuximab Raw Materials
Table 85. Isatuximab Typical Distributors
Table 86. Isatuximab Typical Customers
Table 1. Global Isatuximab Consumption Value by Type, (USD Million), 2021 & 2025 & 2032
Table 2. Global Isatuximab Consumption Value by Specification, (USD Million), 2021 & 2025 & 2032
Table 3. Global Isatuximab Consumption Value by Route of Administration, (USD Million), 2021 & 2025 & 2032
Table 4. Global Isatuximab Consumption Value by Application, (USD Million), 2021 & 2025 & 2032
Table 5. Sanofi Basic Information, Manufacturing Base and Competitors
Table 6. Sanofi Major Business
Table 7. Sanofi Isatuximab Product and Services
Table 8. Sanofi Isatuximab Sales Quantity (Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 9. Sanofi Recent Developments/Updates
Table 10. Sanofi Winthrop Industrie Basic Information, Manufacturing Base and Competitors
Table 11. Sanofi Winthrop Industrie Major Business
Table 12. Sanofi Winthrop Industrie Isatuximab Product and Services
Table 13. Sanofi Winthrop Industrie Isatuximab Sales Quantity (Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 14. Sanofi Winthrop Industrie Recent Developments/Updates
Table 15. Global Isatuximab Sales Quantity by Manufacturer (2021-2026) & (Units)
Table 16. Global Isatuximab Revenue by Manufacturer (2021-2026) & (USD Million)
Table 17. Global Isatuximab Average Price by Manufacturer (2021-2026) & (US$/Unit)
Table 18. Market Position of Manufacturers in Isatuximab, (Tier 1, Tier 2, and Tier 3), Based on Revenue in 2025
Table 19. Head Office and Isatuximab Production Site of Key Manufacturer
Table 20. Isatuximab Market: Company Product Type Footprint
Table 21. Isatuximab Market: Company Product Application Footprint
Table 22. Isatuximab New Market Entrants and Barriers to Market Entry
Table 23. Isatuximab Mergers, Acquisition, Agreements, and Collaborations
Table 24. Global Isatuximab Consumption Value by Region (2021-2025-2032) & (USD Million) & CAGR
Table 25. Global Isatuximab Sales Quantity by Region (2021-2026) & (Units)
Table 26. Global Isatuximab Sales Quantity by Region (2027-2032) & (Units)
Table 27. Global Isatuximab Consumption Value by Region (2021-2026) & (USD Million)
Table 28. Global Isatuximab Consumption Value by Region (2027-2032) & (USD Million)
Table 29. Global Isatuximab Average Price by Region (2021-2026) & (US$/Unit)
Table 30. Global Isatuximab Average Price by Region (2027-2032) & (US$/Unit)
Table 31. Global Isatuximab Sales Quantity by Type (2021-2026) & (Units)
Table 32. Global Isatuximab Sales Quantity by Type (2027-2032) & (Units)
Table 33. Global Isatuximab Consumption Value by Type (2021-2026) & (USD Million)
Table 34. Global Isatuximab Consumption Value by Type (2027-2032) & (USD Million)
Table 35. Global Isatuximab Average Price by Type (2021-2026) & (US$/Unit)
Table 36. Global Isatuximab Average Price by Type (2027-2032) & (US$/Unit)
Table 37. Global Isatuximab Sales Quantity by Application (2021-2026) & (Units)
Table 38. Global Isatuximab Sales Quantity by Application (2027-2032) & (Units)
Table 39. Global Isatuximab Consumption Value by Application (2021-2026) & (USD Million)
Table 40. Global Isatuximab Consumption Value by Application (2027-2032) & (USD Million)
Table 41. Global Isatuximab Average Price by Application (2021-2026) & (US$/Unit)
Table 42. Global Isatuximab Average Price by Application (2027-2032) & (US$/Unit)
Table 43. North America Isatuximab Sales Quantity by Type (2021-2026) & (Units)
Table 44. North America Isatuximab Sales Quantity by Type (2027-2032) & (Units)
Table 45. North America Isatuximab Sales Quantity by Application (2021-2026) & (Units)
Table 46. North America Isatuximab Sales Quantity by Application (2027-2032) & (Units)
Table 47. North America Isatuximab Sales Quantity by Country (2021-2026) & (Units)
Table 48. North America Isatuximab Sales Quantity by Country (2027-2032) & (Units)
Table 49. North America Isatuximab Consumption Value by Country (2021-2026) & (USD Million)
Table 50. North America Isatuximab Consumption Value by Country (2027-2032) & (USD Million)
Table 51. Europe Isatuximab Sales Quantity by Type (2021-2026) & (Units)
Table 52. Europe Isatuximab Sales Quantity by Type (2027-2032) & (Units)
Table 53. Europe Isatuximab Sales Quantity by Application (2021-2026) & (Units)
Table 54. Europe Isatuximab Sales Quantity by Application (2027-2032) & (Units)
Table 55. Europe Isatuximab Sales Quantity by Country (2021-2026) & (Units)
Table 56. Europe Isatuximab Sales Quantity by Country (2027-2032) & (Units)
Table 57. Europe Isatuximab Consumption Value by Country (2021-2026) & (USD Million)
Table 58. Europe Isatuximab Consumption Value by Country (2027-2032) & (USD Million)
Table 59. Asia-Pacific Isatuximab Sales Quantity by Type (2021-2026) & (Units)
Table 60. Asia-Pacific Isatuximab Sales Quantity by Type (2027-2032) & (Units)
Table 61. Asia-Pacific Isatuximab Sales Quantity by Application (2021-2026) & (Units)
Table 62. Asia-Pacific Isatuximab Sales Quantity by Application (2027-2032) & (Units)
Table 63. Asia-Pacific Isatuximab Sales Quantity by Region (2021-2026) & (Units)
Table 64. Asia-Pacific Isatuximab Sales Quantity by Region (2027-2032) & (Units)
Table 65. Asia-Pacific Isatuximab Consumption Value by Region (2021-2026) & (USD Million)
Table 66. Asia-Pacific Isatuximab Consumption Value by Region (2027-2032) & (USD Million)
Table 67. South America Isatuximab Sales Quantity by Type (2021-2026) & (Units)
Table 68. South America Isatuximab Sales Quantity by Type (2027-2032) & (Units)
Table 69. South America Isatuximab Sales Quantity by Application (2021-2026) & (Units)
Table 70. South America Isatuximab Sales Quantity by Application (2027-2032) & (Units)
Table 71. South America Isatuximab Sales Quantity by Country (2021-2026) & (Units)
Table 72. South America Isatuximab Sales Quantity by Country (2027-2032) & (Units)
Table 73. South America Isatuximab Consumption Value by Country (2021-2026) & (USD Million)
Table 74. South America Isatuximab Consumption Value by Country (2027-2032) & (USD Million)
Table 75. Middle East & Africa Isatuximab Sales Quantity by Type (2021-2026) & (Units)
Table 76. Middle East & Africa Isatuximab Sales Quantity by Type (2027-2032) & (Units)
Table 77. Middle East & Africa Isatuximab Sales Quantity by Application (2021-2026) & (Units)
Table 78. Middle East & Africa Isatuximab Sales Quantity by Application (2027-2032) & (Units)
Table 79. Middle East & Africa Isatuximab Sales Quantity by Country (2021-2026) & (Units)
Table 80. Middle East & Africa Isatuximab Sales Quantity by Country (2027-2032) & (Units)
Table 81. Middle East & Africa Isatuximab Consumption Value by Country (2021-2026) & (USD Million)
Table 82. Middle East & Africa Isatuximab Consumption Value by Country (2027-2032) & (USD Million)
Table 83. Isatuximab Raw Material
Table 84. Key Manufacturers of Isatuximab Raw Materials
Table 85. Isatuximab Typical Distributors
Table 86. Isatuximab Typical Customers
LIST OF FIGURES
Figure 1. Isatuximab Picture
Figure 2. Global Isatuximab Revenue by Type, (USD Million), 2021 & 2025 & 2032
Figure 3. Global Isatuximab Revenue Market Share by Type in 2025
Figure 4. Monoclonal Antibody, mAb Examples
Figure 5. Polyclonal Antibody, pAb Examples
Figure 6. Global Isatuximab Revenue by Specification, (USD Million), 2021 & 2025 & 2032
Figure 7. Global Isatuximab Revenue Market Share by Specification in 2025
Figure 8. 100 mg / 5 mL Examples
Figure 9. 500 mg / 25 mL Examples
Figure 10. Global Isatuximab Revenue by Route of Administration, (USD Million), 2021 & 2025 & 2032
Figure 11. Global Isatuximab Revenue Market Share by Route of Administration in 2025
Figure 12. Hospital Examples
Figure 13. Retail Examples
Figure 14. Online Examples
Figure 15. Intravenous Infusion, IV Examples
Figure 16. Subcutaneous Injection, SC Examples
Figure 17. Global Isatuximab Consumption Value by Application, (USD Million), 2021 & 2025 & 2032
Figure 18. Global Isatuximab Revenue Market Share by Application in 2025
Figure 19. Relapsed or Refractory Multiple Myeloma (R/R MM) Examples
Figure 20. Frontline Multiple Myeloma (Frontline MM) Examples
Figure 21. CD38-Positive Hematologic Malignancies Examples
Figure 22. Precision Hematologic Cancer Therapy Examples
Figure 23. Others Examples
Figure 24. Global Isatuximab Consumption Value, (USD Million): 2021 & 2025 & 2032
Figure 25. Global Isatuximab Consumption Value and Forecast (2021-2032) & (USD Million)
Figure 26. Global Isatuximab Sales Quantity (2021-2032) & (Units)
Figure 27. Global Isatuximab Price (2021-2032) & (US$/Unit)
Figure 28. Global Isatuximab Sales Quantity Market Share by Manufacturer in 2025
Figure 29. Global Isatuximab Revenue Market Share by Manufacturer in 2025
Figure 30. Producer Shipments of Isatuximab by Manufacturer Sales ($MM) and Market Share (%): 2025
Figure 31. Top 3 Isatuximab Manufacturer (Revenue) Market Share in 2025
Figure 32. Top 6 Isatuximab Manufacturer (Revenue) Market Share in 2025
Figure 33. Global Isatuximab Sales Quantity Market Share by Region (2021-2032)
Figure 34. Global Isatuximab Consumption Value Market Share by Region (2021-2032)
Figure 35. North America Isatuximab Consumption Value (2021-2032) & (USD Million)
Figure 36. Europe Isatuximab Consumption Value (2021-2032) & (USD Million)
Figure 37. Asia-Pacific Isatuximab Consumption Value (2021-2032) & (USD Million)
Figure 38. South America Isatuximab Consumption Value (2021-2032) & (USD Million)
Figure 39. Middle East & Africa Isatuximab Consumption Value (2021-2032) & (USD Million)
Figure 40. Global Isatuximab Sales Quantity Market Share by Type (2021-2032)
Figure 41. Global Isatuximab Consumption Value Market Share by Type (2021-2032)
Figure 42. Global Isatuximab Average Price by Type (2021-2032) & (US$/Unit)
Figure 43. Global Isatuximab Sales Quantity Market Share by Application (2021-2032)
Figure 44. Global Isatuximab Revenue Market Share by Application (2021-2032)
Figure 45. Global Isatuximab Average Price by Application (2021-2032) & (US$/Unit)
Figure 46. North America Isatuximab Sales Quantity Market Share by Type (2021-2032)
Figure 47. North America Isatuximab Sales Quantity Market Share by Application (2021-2032)
Figure 48. North America Isatuximab Sales Quantity Market Share by Country (2021-2032)
Figure 49. North America Isatuximab Consumption Value Market Share by Country (2021-2032)
Figure 50. United States Isatuximab Consumption Value (2021-2032) & (USD Million)
Figure 51. Canada Isatuximab Consumption Value (2021-2032) & (USD Million)
Figure 52. Mexico Isatuximab Consumption Value (2021-2032) & (USD Million)
Figure 53. Europe Isatuximab Sales Quantity Market Share by Type (2021-2032)
Figure 54. Europe Isatuximab Sales Quantity Market Share by Application (2021-2032)
Figure 55. Europe Isatuximab Sales Quantity Market Share by Country (2021-2032)
Figure 56. Europe Isatuximab Consumption Value Market Share by Country (2021-2032)
Figure 57. Germany Isatuximab Consumption Value (2021-2032) & (USD Million)
Figure 58. France Isatuximab Consumption Value (2021-2032) & (USD Million)
Figure 59. United Kingdom Isatuximab Consumption Value (2021-2032) & (USD Million)
Figure 60. Russia Isatuximab Consumption Value (2021-2032) & (USD Million)
Figure 61. Italy Isatuximab Consumption Value (2021-2032) & (USD Million)
Figure 62. Asia-Pacific Isatuximab Sales Quantity Market Share by Type (2021-2032)
Figure 63. Asia-Pacific Isatuximab Sales Quantity Market Share by Application (2021-2032)
Figure 64. Asia-Pacific Isatuximab Sales Quantity Market Share by Region (2021-2032)
Figure 65. Asia-Pacific Isatuximab Consumption Value Market Share by Region (2021-2032)
Figure 66. China Isatuximab Consumption Value (2021-2032) & (USD Million)
Figure 67. Japan Isatuximab Consumption Value (2021-2032) & (USD Million)
Figure 68. South Korea Isatuximab Consumption Value (2021-2032) & (USD Million)
Figure 69. India Isatuximab Consumption Value (2021-2032) & (USD Million)
Figure 70. Southeast Asia Isatuximab Consumption Value (2021-2032) & (USD Million)
Figure 71. Australia Isatuximab Consumption Value (2021-2032) & (USD Million)
Figure 72. South America Isatuximab Sales Quantity Market Share by Type (2021-2032)
Figure 73. South America Isatuximab Sales Quantity Market Share by Application (2021-2032)
Figure 74. South America Isatuximab Sales Quantity Market Share by Country (2021-2032)
Figure 75. South America Isatuximab Consumption Value Market Share by Country (2021-2032)
Figure 76. Brazil Isatuximab Consumption Value (2021-2032) & (USD Million)
Figure 77. Argentina Isatuximab Consumption Value (2021-2032) & (USD Million)
Figure 78. Middle East & Africa Isatuximab Sales Quantity Market Share by Type (2021-2032)
Figure 79. Middle East & Africa Isatuximab Sales Quantity Market Share by Application (2021-2032)
Figure 80. Middle East & Africa Isatuximab Sales Quantity Market Share by Country (2021-2032)
Figure 81. Middle East & Africa Isatuximab Consumption Value Market Share by Country (2021-2032)
Figure 82. Turkey Isatuximab Consumption Value (2021-2032) & (USD Million)
Figure 83. Egypt Isatuximab Consumption Value (2021-2032) & (USD Million)
Figure 84. Saudi Arabia Isatuximab Consumption Value (2021-2032) & (USD Million)
Figure 85. South Africa Isatuximab Consumption Value (2021-2032) & (USD Million)
Figure 86. Isatuximab Market Drivers
Figure 87. Isatuximab Market Restraints
Figure 88. Isatuximab Market Trends
Figure 89. Porters Five Forces Analysis
Figure 90. Manufacturing Cost Structure Analysis of Isatuximab in 2025
Figure 91. Manufacturing Process Analysis of Isatuximab
Figure 92. Isatuximab Industrial Chain
Figure 93. Sales Channel: Direct to End-User vs Distributors
Figure 94. Direct Channel Pros & Cons
Figure 95. Indirect Channel Pros & Cons
Figure 96. Methodology
Figure 97. Research Process and Data Source
Figure 1. Isatuximab Picture
Figure 2. Global Isatuximab Revenue by Type, (USD Million), 2021 & 2025 & 2032
Figure 3. Global Isatuximab Revenue Market Share by Type in 2025
Figure 4. Monoclonal Antibody, mAb Examples
Figure 5. Polyclonal Antibody, pAb Examples
Figure 6. Global Isatuximab Revenue by Specification, (USD Million), 2021 & 2025 & 2032
Figure 7. Global Isatuximab Revenue Market Share by Specification in 2025
Figure 8. 100 mg / 5 mL Examples
Figure 9. 500 mg / 25 mL Examples
Figure 10. Global Isatuximab Revenue by Route of Administration, (USD Million), 2021 & 2025 & 2032
Figure 11. Global Isatuximab Revenue Market Share by Route of Administration in 2025
Figure 12. Hospital Examples
Figure 13. Retail Examples
Figure 14. Online Examples
Figure 15. Intravenous Infusion, IV Examples
Figure 16. Subcutaneous Injection, SC Examples
Figure 17. Global Isatuximab Consumption Value by Application, (USD Million), 2021 & 2025 & 2032
Figure 18. Global Isatuximab Revenue Market Share by Application in 2025
Figure 19. Relapsed or Refractory Multiple Myeloma (R/R MM) Examples
Figure 20. Frontline Multiple Myeloma (Frontline MM) Examples
Figure 21. CD38-Positive Hematologic Malignancies Examples
Figure 22. Precision Hematologic Cancer Therapy Examples
Figure 23. Others Examples
Figure 24. Global Isatuximab Consumption Value, (USD Million): 2021 & 2025 & 2032
Figure 25. Global Isatuximab Consumption Value and Forecast (2021-2032) & (USD Million)
Figure 26. Global Isatuximab Sales Quantity (2021-2032) & (Units)
Figure 27. Global Isatuximab Price (2021-2032) & (US$/Unit)
Figure 28. Global Isatuximab Sales Quantity Market Share by Manufacturer in 2025
Figure 29. Global Isatuximab Revenue Market Share by Manufacturer in 2025
Figure 30. Producer Shipments of Isatuximab by Manufacturer Sales ($MM) and Market Share (%): 2025
Figure 31. Top 3 Isatuximab Manufacturer (Revenue) Market Share in 2025
Figure 32. Top 6 Isatuximab Manufacturer (Revenue) Market Share in 2025
Figure 33. Global Isatuximab Sales Quantity Market Share by Region (2021-2032)
Figure 34. Global Isatuximab Consumption Value Market Share by Region (2021-2032)
Figure 35. North America Isatuximab Consumption Value (2021-2032) & (USD Million)
Figure 36. Europe Isatuximab Consumption Value (2021-2032) & (USD Million)
Figure 37. Asia-Pacific Isatuximab Consumption Value (2021-2032) & (USD Million)
Figure 38. South America Isatuximab Consumption Value (2021-2032) & (USD Million)
Figure 39. Middle East & Africa Isatuximab Consumption Value (2021-2032) & (USD Million)
Figure 40. Global Isatuximab Sales Quantity Market Share by Type (2021-2032)
Figure 41. Global Isatuximab Consumption Value Market Share by Type (2021-2032)
Figure 42. Global Isatuximab Average Price by Type (2021-2032) & (US$/Unit)
Figure 43. Global Isatuximab Sales Quantity Market Share by Application (2021-2032)
Figure 44. Global Isatuximab Revenue Market Share by Application (2021-2032)
Figure 45. Global Isatuximab Average Price by Application (2021-2032) & (US$/Unit)
Figure 46. North America Isatuximab Sales Quantity Market Share by Type (2021-2032)
Figure 47. North America Isatuximab Sales Quantity Market Share by Application (2021-2032)
Figure 48. North America Isatuximab Sales Quantity Market Share by Country (2021-2032)
Figure 49. North America Isatuximab Consumption Value Market Share by Country (2021-2032)
Figure 50. United States Isatuximab Consumption Value (2021-2032) & (USD Million)
Figure 51. Canada Isatuximab Consumption Value (2021-2032) & (USD Million)
Figure 52. Mexico Isatuximab Consumption Value (2021-2032) & (USD Million)
Figure 53. Europe Isatuximab Sales Quantity Market Share by Type (2021-2032)
Figure 54. Europe Isatuximab Sales Quantity Market Share by Application (2021-2032)
Figure 55. Europe Isatuximab Sales Quantity Market Share by Country (2021-2032)
Figure 56. Europe Isatuximab Consumption Value Market Share by Country (2021-2032)
Figure 57. Germany Isatuximab Consumption Value (2021-2032) & (USD Million)
Figure 58. France Isatuximab Consumption Value (2021-2032) & (USD Million)
Figure 59. United Kingdom Isatuximab Consumption Value (2021-2032) & (USD Million)
Figure 60. Russia Isatuximab Consumption Value (2021-2032) & (USD Million)
Figure 61. Italy Isatuximab Consumption Value (2021-2032) & (USD Million)
Figure 62. Asia-Pacific Isatuximab Sales Quantity Market Share by Type (2021-2032)
Figure 63. Asia-Pacific Isatuximab Sales Quantity Market Share by Application (2021-2032)
Figure 64. Asia-Pacific Isatuximab Sales Quantity Market Share by Region (2021-2032)
Figure 65. Asia-Pacific Isatuximab Consumption Value Market Share by Region (2021-2032)
Figure 66. China Isatuximab Consumption Value (2021-2032) & (USD Million)
Figure 67. Japan Isatuximab Consumption Value (2021-2032) & (USD Million)
Figure 68. South Korea Isatuximab Consumption Value (2021-2032) & (USD Million)
Figure 69. India Isatuximab Consumption Value (2021-2032) & (USD Million)
Figure 70. Southeast Asia Isatuximab Consumption Value (2021-2032) & (USD Million)
Figure 71. Australia Isatuximab Consumption Value (2021-2032) & (USD Million)
Figure 72. South America Isatuximab Sales Quantity Market Share by Type (2021-2032)
Figure 73. South America Isatuximab Sales Quantity Market Share by Application (2021-2032)
Figure 74. South America Isatuximab Sales Quantity Market Share by Country (2021-2032)
Figure 75. South America Isatuximab Consumption Value Market Share by Country (2021-2032)
Figure 76. Brazil Isatuximab Consumption Value (2021-2032) & (USD Million)
Figure 77. Argentina Isatuximab Consumption Value (2021-2032) & (USD Million)
Figure 78. Middle East & Africa Isatuximab Sales Quantity Market Share by Type (2021-2032)
Figure 79. Middle East & Africa Isatuximab Sales Quantity Market Share by Application (2021-2032)
Figure 80. Middle East & Africa Isatuximab Sales Quantity Market Share by Country (2021-2032)
Figure 81. Middle East & Africa Isatuximab Consumption Value Market Share by Country (2021-2032)
Figure 82. Turkey Isatuximab Consumption Value (2021-2032) & (USD Million)
Figure 83. Egypt Isatuximab Consumption Value (2021-2032) & (USD Million)
Figure 84. Saudi Arabia Isatuximab Consumption Value (2021-2032) & (USD Million)
Figure 85. South Africa Isatuximab Consumption Value (2021-2032) & (USD Million)
Figure 86. Isatuximab Market Drivers
Figure 87. Isatuximab Market Restraints
Figure 88. Isatuximab Market Trends
Figure 89. Porters Five Forces Analysis
Figure 90. Manufacturing Cost Structure Analysis of Isatuximab in 2025
Figure 91. Manufacturing Process Analysis of Isatuximab
Figure 92. Isatuximab Industrial Chain
Figure 93. Sales Channel: Direct to End-User vs Distributors
Figure 94. Direct Channel Pros & Cons
Figure 95. Indirect Channel Pros & Cons
Figure 96. Methodology
Figure 97. Research Process and Data Source
